The South African Stroke Risk in General Practice Study by Connor, Myles et al.
ORIGINAL ARTICLES 
The South African Stroke Risk in General Practice Study 
Myles Connor, Paul Rheeder, Alan Bryer, Megan Meredith, Marlene Beukes, Asher Dubb and Vivian Fritz, on behalf of the 
Southern African Stroke Foundation 
Background. Incidence of stroke is increasing in sub-Saharan 
Africa and stroke prevention is an essential component of 
successful stroke management. General practitioners (GPs) 
ate well placed to manage stroke risk factors. To design 
appropriate strategies for risk factor reduction we need to 
know the risk factor prevalence in each of the population 
groups attending GPs. The aim of this study was to establish 
the prevalence of stroke risk factors in the South African 
general practice population. 
Method. We conducted a multicentre, observational study of 
patients attending general practice in South Africa. Two 
hundred general practices were randomly selected from lists 
provided by pharmaceutical .representatives. Each GP 
approached 50 consecutive patients aged 30 years and older. 
Patients completed an information sheet and the GP 
documented the patient's risk factors. The resulting sample is 
relevant.if not necessarily representative in a statistical sense. 
Stroke is the third commonest cause of death worldwide and 
over two-thirds of those deaths occur in developing regions such 
as sub-Saharan Africa.' Local South African vital registration 
figures' and a verbal autopsy study from the Agincourt Health 
and Population Unit,' a rural demographic surveillance site in 
Limpopo province, confirm that stroke is an increasingly 
important cause of death in South Africa. But most people 
survive stroke and about half are disabled,' placing an enormous 
burden on the survivors, their families and the community. 
The acute management of stroke has improved dramatically 
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Results. A total of 9 731 questionnaires were returned out of a 
possible 10 000. The mean age of particpants was 50.7 years. 
Seventy-six per cent had 1 or more risk factors and 40% had 2 
or more risk factors. Hypertension was the commonest risk 
factor in all population groups (55%) but was highest in black 
patients (59%). Dyslipidaemia was commonest in whites 
(37%) and least common in blacks (5%). Diabetes was 
commonest in Asians (24%) but least common in whites (8%). 
Risk factors other than smoking increased with age. 
Conclusion. This study provides unique data on the 
prevalence of stroke risk factors in a South African general 
practice population. Risk factors are common in all 
population groups, but differ in distribution among the 
groups. There is considerable opportunity to reduce the 
burden of stroke in South Africa through GP screening for 
and treatment of risk factors. 
S Afr Med J 2005; 95: 334-339. 
ove the last decade with the introduction of stroke units, stroke 
management protocols and national guidelines,' and acute 
treatments such as thrombolysis.'·' However, the most cost-
effictive approach to management is to prevent the stroke in the 
first place.8 To do this we need to reduce the individual patient's 
stroke risk factors (high-risk strategy), and reduce risk factors 
throughout the population (mass strategy). 
Conventional stroke risk factors are divided into those we 
cannot influence such as increasing age, male gender, family 
history, socio-economic status and race; and those we can 
potentially influence such as hypertension, diabetes mellitus 
(DM), atrial fibrillation, smoking, hypercholesterolaemia, 
exessive alcohol intake, obesity, physical inactivity, and 
prothrombotic factors.' One of the most important risk factors 
for recurrent stroke is prior stroke or transient ischaemic attack 
(TIA). About 30% of people who have had a stroke or TIA will 
have another stroke during the following 5 years; and almost 
half of these will occur within 6 months to a year of the initial 
event.'-10 Appropriate secondary prevention reduces this risk 
significantly.n General practitioners (GPs) play a major role in 
detecting and treating modifiable risk factors and implementing 
primary and secondary stroke prevention measures. 
It is well established that the relative importance of risk factors 
for stroke and cardiovascular disease differs between 
populations."-14 If we are to design locally appropriate strategies 
to address risk factor reduction within the general practice 
population to facilitate both the high-risk and practice 
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population, then we need to know the prevalence of risk factors 
in each of the South African population groups. The aim of this 
study was to establish the prevalence of the most important 
stroke risk factors in the South African general practice 
population to facilitate both the high-risk and population 
approaches to stroke prevention. 
Methods 
We conducted a multicentre, observational study of patients 
attending general practice in South Africa. 
Participant selection 
Seventeen pharmaceutical company representatives 
countrywide were asked to submit a list of the names of 40 
GPs in their respective areas (680 practices in total nationally). In 
order to include 200 general practices, we randomly selected 12 
- 13 on each representative's list, with a further 1 or 2 as a 
backup to replace GPs who refused to participate. The GPs were 
therefore not selected on the basis of any specific characteristic 
that could have influenced the results. 
Each consenting GP approached 50 consecutive patients aged 
30 years or older to participate in the study. Patients were given 
an information sheet and written consent was obtained before 
including them in the study. Only demographic data were 
recorded for patients who refused consent. Management of 
patients with risk factors was left to the GPs' discretion. 
Risk-factor assessment and definitions 
The GPs completed a 5-page questionnaire for each participating 
patient during the standard consultation for which the patient 
had attended the practice. The questionnaire included risk-factor 
and demographic information. The patient's most recent blood 
pressure (BP) measurement was documented. We defined 
hypertension as past history of hypertension or a current 
presentation with a systolic BP ;, 140 mmHg, or a diastolic BP of 
;, 90 mmHg. The highest result in the past 12 months for fasting 
total cholesterol, high-density lipoprotein (HDL), low-density 
lipoprotein (LDL), triglycerides and blood glucose were 
recorded if available. We defined dyslipidaemia as a past history 
of hypercholesterolaemia or a current presentation with a fasting 
cholesterol level > 
5 mmol/1 or LDL level > 3 mmol/l. DM was defined as a past 
history of DM or a current presentation with a fasting blood 
glucose level of ;, 7 mmol/l. Current smoking status, a history of 
ever having smoked, alcohol use and a history of previous 
stroke or TIA were noted. A current presentation or history of 
heart failure, ischaemic heart disease or venous thromboembolic 
event were also recorded. We defined atrial fibrillation as a past 
history of atrial fibrillation or a current presentation with atrial 
fibrillation or an irregular pulse rate. Current use of medication 
for cardiovascular risk factors was documented, as was a current 
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presentation or past history of motor, sensory, speech, or 
cerebellar abnormalities, double vision, amaurosis fugax or 
dizziness. 
Data analysis 
Data were entered in Epilnfo and analysed using Stata 8. 
Descriptive statistics included the mean and standard deviations 
(SDs) as well as proportion with confidence intervals (Cis). We 
assessed the difference between population groups with regard 
to risk factors using chi-square tests. The distribution of the 
number of risk factors between the ethnic groups was compared 
using a Kruskal-Wallis test with adjusment after post hoc 
comparisons. We used logistical regression to determine the 
odds ratios (ORs) of the different population group categories 
for the various risk factors after adjusting for differences in age 
and gender. 
Ethics 
The Medicines Control Council confirmed that no formal 
approval was required other than ethics committee approval, as 
no drug was to be used in the study. Ethics committee approval 
was obtained from the University of Pretoria (120/2001) and 
Pharma-Ethics (ICE-9490 012-ZAF) 
Results 
Demographics 
Two hundred general practices were registered after 79 of the 
randomised GPs who refused to participate had been replaced 
by others in the same geographical area, as close as possible to 
the original randomised practice. A total of 9 731 questionnaires 
were returned. Data were available for 199 practices as 1 practice 
submitted questionnaires after the deadline date. The national 
distribution of participants was as follows (the percentage of the 
study sample and for comparison the percentage of the total 
South African population in the region are given in brackets for 
each region): Gauteng/Mpumalanga 2 689 participants (29%; 
25%); Western Cape 1 744 participants (19%, 10%); KwaZulu-
Natal1 609 participants (18%, 21 %); Limpopo Province 1 506 
participants (17%, 12%); Central Provinces 855 participants (9%, 
17%); and Eastern Cape 544 participants (6%,16%).15 Although 
participating patients were widely distributed across South 
Africa, the majority were seen in metropolitan cities and rural 
areas were underrepresented. 
Six per cent of participants (N = 618) were ineligible for liD 
analysis because of refusal (N = 303), missing most data (N = 
187), or not meeting the inclusion criteria, e.g. under 30 years of 
age (N = 128). A total of 9 133 participants were therefore 
included and 303 non-participants excluded because of either 
patient refusal or doctor refusal to enter a particular individual. 
The mean age of participants was 50.7 years (SD 13.9, range 30-
1m 
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100 years) and 73% of the participants were in the 30- 59-year 
age range. The sex and population group distribution of 
participants and non-participants (because of refusal) was 
similar. Forty-five per cent of both the participants and non-
participants were male, 23% of the participants were black, 7% 
coloured, 10% Asian, and 59% white; while 28% of the non-
participants were black, 7% coloured, 8% Asian and 56% white. 
Not all participants had all risk factors recorded. Only 31% 
had a total cholesterol reported and 40% had glucose values 
reported. In contrast, 96% of all participants had BP readings 
reported. Unfortunately, the proportion of tests done varied 
significantly among population groups. The proportion of each 
population group that had glucose values reported was as 
follows: black 30%, coloured 38%, Asian 55%, and white 41% 
(p < 0.001). The proportions for total cholesterol were: black 8%, 
coloured 22%, Asian 22% and white 43% (p < -0.001). 
Risk factors 
Seventy-six per cent of patients had 1 or more risk factors and 
40% had 2 or more risk factors. There was a statistically 
significant difference (p < 0.001) in the number of risk factors 
between population groups. Post hoc testing showed that this 
distribution was significantly different between all groups except 
between the coloureds and Asians (p = 0.15, p < 0.004) required 
for significance). Of the 24% with no reported risk factors, the 
majority (32%) were black patients. Three or more risk factors 
occurred almost as commonly in the Asian, white and coloured 
groups (11 -14%), but far less commonly in the black group 
(4%). 
Table I shows the prevalence of risk factors by population 
group. Figs 1 - 3 graphically compare the prevalence of 
hypertension, dyslipidaemia, and a history of ever having 
smoked cigarettes by age group and population group. 
Hypertension is clearly the commonest risk factor in all 
population groups but stands out as the major risk factor in 
black patients. Logistical regression revealed that whites were 
44% less likely to have hypertension than blacks even having 
adjusted for age and gender (OR 0.66, 95% CI: 0.59- 0.74). The 
proportion of people still hypertensive despite treatment was 
47%. 
Whites were 10 times more likely to have dyslipidaemia than 
those blacks for whom information was available (OR 10.2, 95% 
Cl: 8.3 - 12.5). As expected, DM was most common in the Asian 
population (26%) but surprisingly least common in the white 
population (8%). Most risk factors except cigarette smoking 
increased with age. 
Atrial fibrillation was commonest in the white population 
(5%) followed by the coloured population (4%), and about 
equally common in the black and Asian population (2%). 
Current or past heart failure and venous thromboembolism were 
each present in 4% of participants. Ischaemic heart disease (past 
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Fig. 1. Prevalence of hypertension by sex, age group and population 
group (age group 1 = 30- 49, age group 2 =50- 69, age group 
3 = 70+). 
Table I. Risk-factor prevalence (percentage) by population group, adjusted for age and gender (95% confidence intervals) 
Risk factor Black Coloured Asian White Total 
Hypertension 59 (57- 61) 55 (52- 59) 55 (52- 58) 50 (49- 52) 55 
Diabetes mellitus 14 (12- 15) 15 (12- 18) 26 (23- 29) 8 (7- 8) 16 
Dyslipidaemia 5 (4- 6) 23 (20- 27) 22 (19- 25) 37 (35- 38) 22 
History of ever smoking cigarettes 21 (20- 23) 44 (40- 48) 26 (24- 29) 42 (41 - 44) 33 
Atrial fibrillation 2 (2- 3) 4 (2- 6) 2 (1 - 3) 5 (5-6) 3 
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Routinely available cotrimoxazole prophylaxis and 
occurrence of respiratory and diarrhoeal morbidity in 
infants born to HIV-infected mothers in South Africa 
Anna Coutsoudis, Kubendran Pillay, Elizabeth Spooner, Hoosen M Coovadia, Lucy Pembrey, Marie-Louise Newell 
Objectives. To examine the influence of cotrimoxazole (CTM) 
prophylaxis on incidence of lower respiratory tract infections 
(LRTis) and diarrhoea. 
Design. A prospective observational cohort study. Morbidity 
and feeding data on infants born to HN-infected mothers 
were collected routinely at. clink visits at 1 week, 6 weeks and 
3 months, and 3-monthly thereafter, with blood drawn for 
determining HIV status. 
Setting. Two hospitals in Durban, South Africa. In one 
hospital (King Edward VIII Hospital), infants born to HIV-
infected mothers recieved CTM prophylaxis and in the other 
(McCord Hospital) infants did not receive CTM prophylaxis, 
Subjects. Infants born to HIV-infected mothers. 
Outcome measures. Incidence of .LRTI and diarrhoea. 
Results, Ill. multivariate analysis controlling for breast-feeding 
status, number of clinic visits and HN infection status, HIV-
infected infants with access to C1M prophylaxis had a 
significantly lower incidence of LRTI (82%) than those 
without access to prophylaxis. However in HIV-uninfected 
infants, this was not the case, CTM prophylaxis was 
associated with a non-significant increased risk for diarrhoea 
in both infected (odds ratio (OR) 1.58, p = 0.45) aud unin-
fected infants (OR 1.52, p = 0.10). 
Conclusions, This observational study .confirms current 
thinking that CTM prophylaxis is protective against LRTis in 
HIV-infected children. However, because of a possible 
association between CTM prophylaxis and an increased risk 
of diarrhoea, HIV status of infants should be determined as 
early as possible in order to prevent tmnecessary exposure of 
uninfected infants to CTM prophylaxis, while further studies 
to quantify both beneficial and adverse effects. of CTM 
prophylaxis are undertaken. 
S Afr Med J 2005; 95: 339-345 
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